Deutsche Bank’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
23,709
-5,160
| -18% | -$224K | ﹤0.01% | 2066 |
|
|
2025
Q1 | $1.08M | Sell |
28,869
-2,870
| -9% | -$107K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $1.44M | Buy |
31,739
+10,709
| +51% | +$485K | ﹤0.01% | 2021 |
|
|
2024
Q3 | $1.24M | Buy |
21,030
+4,836
| +30% | +$284K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $637K | Sell |
16,194
-3,012
| -16% | -$119K | ﹤0.01% | 2189 |
|
|
2024
Q1 | $1.28M | Buy |
19,206
+11,535
| +150% | +$767K | ﹤0.01% | 1855 |
|
|
2023
Q4 | $214K | Buy |
7,671
+3,064
| +67% | +$85.6K | ﹤0.01% | 2792 |
|
|
2023
Q3 | $98.1K | Buy |
+4,607
| New | +$98.1K | ﹤0.01% | 3143 |
|